Cambridge, Massachusetts
United States
29
2024-12-26
23
2024-12-24
These are the the leading inventors for applications assigned to Synlogic Operating Company, Inc.:
Synlogic Operating Company, Inc. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ENGINEERED PHENYLALANINE AMMONIA LYASE ENZYMES
#2 | 2024-06-20BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS DETRIMENTAL
#3 | 2024-04-04BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER
#4 | 2024-04-04ENGINEERED MICROORGANISMS
#5 | 2024-03-14 ✅ Patent 12,171,790 granted on 2024-12-24Microorganisms engineered to reduce hyperphenylalaninemia
#6 | 2023-03-02 ✅ Patent 11,859,189 granted on 2024-01-02Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof
#7 | 2022-11-17 ✅ Patent 11,766,463 granted on 2023-09-26Microorganisms engineered to reduce hyperphenylalaninemia
#8 | 2022-11-03BIOSYNTHESIS OF ENZYMES FOR USE IN TREATMENT OF MAPLE SYRUP URINE DISEASE (MSUD)
#9 | 2022-07-21 ✅ Patent 11,896,627 granted on 2024-02-13Bacteria engineered to treat metabolic diseases
#10 | 2021-06-17 ✅ Patent 11,845,964 granted on 2023-12-19Bacteria engineered to treat diseases associated with hyperammonemia
#11 | 2021-06-10 ✅ Patent 11,883,439 granted on 2024-01-30Bacteria engineered to treat a disease or disorder
#12 | 2021-05-27 ✅ Patent 11,439,673 granted on 2022-09-13Bacteria engineered to treat liver disease
#13 | 2021-04-01Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal Barrier
#14 | 2020-08-06 ✅ Patent 12,409,195 granted on 2025-09-09Bacteria Engineered to Reduce Hyperphenylalaninemia
#15 | 2020-06-04 ✅ Patent 11,879,123 granted on 2024-01-23Bacteria for the treatment of disorders
#16 | 2019-11-28 ✅ Patent 11,060,073 granted on 2021-07-13Bacteria engineered to treat diseases associated with hyperammonemia
#17 | 2019-11-07 ✅ Patent 11,471,494 granted on 2022-10-18Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
#18 | 2019-10-03 ✅ Patent 11,291,693 granted on 2022-04-05Bacteria engineered to treat metabolic diseases
#19 | 2019-05-30 ✅ Patent 11,723,932 granted on 2023-08-15Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
#20 | 2018-11-15 ✅ Patent 11,273,184 granted on 2022-03-15Bacteria engineered to treat disorders in which oxalate is detrimental
#21 | 2018-11-08 ✅ Patent 11,618,894 granted on 2023-04-04Bacteria engineered to reduce hyperphenylalaninemia
#22 | 2018-11-01 ✅ Patent 11,685,925 granted on 2023-06-27Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
#23 | 2018-10-04 ✅ Patent 10,933,102 granted on 2021-03-02Bacteria engineered to treat a disease or disorder
#24 | 2018-06-21 ✅ Patent 10,933,102 granted on 2021-03-02Bacteria engineered to treat a disease or disorder
#25 | 2017-11-02 ✅ Patent 10,195,234 granted on 2019-02-05Bacteria engineered to reduce hyperphenylalaninemia
#26 | 2017-09-07 ✅ Patent 11,060,073 granted on 2021-07-13Bacteria engineered to treat diseases associated with hyperammonemia
#27 | 2017-05-11 ✅ Patent 10,273,489 granted on 2019-04-30Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
#28 | 2017-03-09 ✅ Patent 11,384,359 granted on 2022-07-12Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
#29 | 2016-11-24 ✅ Patent 10,610,546 granted on 2020-04-07Bacteria engineered to reduce hyperphenylalaninemia
Also check out Synlogic Operating Company, Inc.'s (Cambridge, United States) applicant profile with 33 patent applications submitted.
170603 ⎘